154 related articles for article (PubMed ID: 19657787)
1. Coagulation activation and fluid retention associated with the use of black cohosh: a case study.
Zimmermann R; Witte A; Voll RE; Strobel J; Frieser M
Climacteric; 2010 Apr; 13(2):187-91. PubMed ID: 19657787
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of black cohosh (Cimicifuga racemosa) medicines for treatment of menopausal symptoms - comments on major statements of the Cochrane Collaboration report 2012 "black cohosh (Cimicifuga spp.) for menopausal symptoms (review)".
Beer AM; Osmers R; Schnitker J; Bai W; Mueck AO; Meden H
Gynecol Endocrinol; 2013 Dec; 29(12):1022-5. PubMed ID: 23992293
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune hepatitis associated with the use of black cohosh: a case study.
Cohen SM; O'Connor AM; Hart J; Merel NH; Te HS
Menopause; 2004; 11(5):575-7. PubMed ID: 15356412
[TBL] [Abstract][Full Text] [Related]
4. Black cohosh: a cause of abnormal postmenopausal liver function tests.
Joy D; Joy J; Duane P
Climacteric; 2008 Feb; 11(1):84-8. PubMed ID: 18202968
[TBL] [Abstract][Full Text] [Related]
5. Muscle damage induced by black cohosh (Cimicifuga racemosa).
Minciullo PL; Saija A; Patafi M; Marotta G; Ferlazzo B; Gangemi S
Phytomedicine; 2006 Jan; 13(1-2):115-8. PubMed ID: 16360941
[TBL] [Abstract][Full Text] [Related]
6. Review of alternative therapies for treatment of menopausal symptoms.
Amato P; Marcus DM
Climacteric; 2003 Dec; 6(4):278-84. PubMed ID: 15006249
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms.
Osmers R; Friede M; Liske E; Schnitker J; Freudenstein J; Henneicke-von Zepelin HH
Obstet Gynecol; 2005 May; 105(5 Pt 1):1074-83. PubMed ID: 15863547
[TBL] [Abstract][Full Text] [Related]
8. Black cohosh with or without St. John's wort for symptom-specific climacteric treatment--results of a large-scale, controlled, observational study.
Briese V; Stammwitz U; Friede M; Henneicke-von Zepelin HH
Maturitas; 2007 Aug; 57(4):405-14. PubMed ID: 17590291
[TBL] [Abstract][Full Text] [Related]
9. Fulminant hepatic failure associated with the use of black cohosh: a case report.
Lynch CR; Folkers ME; Hutson WR
Liver Transpl; 2006 Jun; 12(6):989-92. PubMed ID: 16721764
[TBL] [Abstract][Full Text] [Related]
10. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity.
Mahady GB; Low Dog T; Barrett ML; Chavez ML; Gardiner P; Ko R; Marles RJ; Pellicore LS; Giancaspro GI; Sarma DN
Menopause; 2008; 15(4 Pt 1):628-38. PubMed ID: 18340277
[TBL] [Abstract][Full Text] [Related]
11. Black cohosh: efficacy, safety, and use in clinical and preclinical applications.
McKenna DJ; Jones K; Humphrey S; Hughes K
Altern Ther Health Med; 2001; 7(3):93-100. PubMed ID: 11347288
[TBL] [Abstract][Full Text] [Related]
12. Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract.
Naser B; Schnitker J; Minkin MJ; de Arriba SG; Nolte KU; Osmers R
Menopause; 2011 Apr; 18(4):366-75. PubMed ID: 21228727
[TBL] [Abstract][Full Text] [Related]
13. Menopause: a standardized isopropanolic black cohosh extract (remifemin) is found to be safe and effective for menopausal symptoms.
Ross SM
Holist Nurs Pract; 2012; 26(1):58-61. PubMed ID: 22157510
[TBL] [Abstract][Full Text] [Related]
14. Severe hepatitis associated with the use of black cohosh: a report of two cases and an advice for caution.
Pierard S; Coche JC; Lanthier P; Dekoninck X; Lanthier N; Rahier J; Geubel AP
Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):941-5. PubMed ID: 19404202
[TBL] [Abstract][Full Text] [Related]
15. Coadministration of the aromatase inhibitor formestane and an isopropanolic extract of black cohosh in a rat model of chemically induced mammary carcinoma.
Nisslein T; Freudenstein J
Planta Med; 2007 Apr; 73(4):318-22. PubMed ID: 17354167
[TBL] [Abstract][Full Text] [Related]
16. Black cohosh (Actaea/Cimicifuga racemosa): review of the clinical data for safety and efficacy in menopausal symptoms.
Mahady GB
Treat Endocrinol; 2005; 4(3):177-84. PubMed ID: 15898823
[TBL] [Abstract][Full Text] [Related]
17. The safety of black cohosh (Actaea racemosa, Cimicifuga racemosa).
Huntley A
Expert Opin Drug Saf; 2004 Nov; 3(6):615-23. PubMed ID: 15500420
[TBL] [Abstract][Full Text] [Related]
18. Black cohosh: coming full circle?
Johnson TL; Fahey JW
J Ethnopharmacol; 2012 Jun; 141(3):775-9. PubMed ID: 22504147
[TBL] [Abstract][Full Text] [Related]
19. An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women.
Hirschberg AL; Edlund M; Svane G; Azavedo E; Skoog L; von Schoultz B
Menopause; 2007; 14(1):89-96. PubMed ID: 17019374
[TBL] [Abstract][Full Text] [Related]
20. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
